background image

Paid Clinical Trials Dallas

Discover 1,818 paid clinical trials in Dallas, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1
PHASE2

Sponsor:

Moderna

Location:

Fort Worth TX, Norman OK, Austin TX, Tomball TXshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Dallas TX, Frisco TX, McKinney TX, Corsicana TXshow 70 more

Code:

NCT06307665

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

BDA MDI

AS MDI

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Recruiting
PHASE1
PHASE2

Sponsor:

Amgen

Location:

Dallas TX, Irving TX, Tyler TX, Houston TXshow 9 more

Code:

NCT05325866

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bemarituzumab

A Study to Evaluate the Effect of Aficamten in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

Recruiting
PHASE2
PHASE3

Sponsor:

Cytokinetics

Location:

Dallas TX, Memphis TN, New Orleans LA, Kansas City MOshow 18 more

Code:

NCT06412666

Conditions

Pediatric

Symptomatic Obstructive Hypertrophic Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Aficamten

Placebo

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Dallas TX, Lewisville TX, Houston TX, Wichita KSshow 41 more

Code:

NCT04616326

Conditions

Chronic Migraine

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Galcanezumab

Placebo

A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

Recruiting

Sponsor:

Sarepta Therapeutics, Inc.

Location:

Dallas TX, Little Rock AR, Chicago IL, Phoenix AZshow 8 more

Code:

NCT04475926

Conditions

Limb-girdle Muscular Dystrophy

Eligibility Criteria

Sex: All

Age: 4+

Healthy Volunteers: Not accepted

Financial Support in an Underserved and Low-Income Population With Heart Failure

Recruiting

Sponsor:

University of Texas Southwestern Medical Center

Location:

Dallas TX

Code:

NCT05928026

Conditions

Heart Failure, Systolic

Financial Stress

Medication Adherence

Quality of Life

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Financial Support

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

Recruiting
PHASE3

Sponsor:

VistaGen Therapeutics, Inc.

Location:

Dallas TX, Austin TX, Houston TX, Little Rock ARshow 12 more

Code:

NCT06615557

Conditions

Social Anxiety Disorder (SAD)

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Fasedienol Nasal Spray

Placebo Nasal Spray

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Recruiting
PHASE3

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Plano TX, Houston TX, Tulsa OK, Little Rock ARshow 45 more

Code:

NCT04045665

Conditions

Atrial Fibrillation

Stroke

Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Antiplatelet-only strategy

Oral Anticoagulant plus background antiplatelet therapy

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Irving TX, Georgetown TX, Austin TX, Conroe TXshow 172 more

Code:

NCT05026866

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

Donanemab

Placebo

Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)

Recruiting

Sponsor:

North Texas Veterans Healthcare System

Location:

Dallas TX, Oklahoma City OK, Lubbock TX, Omaha NEshow 7 more

Code:

NCT02660866

Conditions

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo + background APT + SMT

Vorapaxar 2.08 mg/d + background APT + SMT.

Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

Recruiting
PHASE3

Sponsor:

Introgen Therapeutics

Location:

Dallas TX, Houston TX, Little Rock AR, Aurora COshow 4 more

Code:

NCT00041626

Conditions

Carcinoma, Squamous Cell

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

INGN 201

Dallas is a key hub for clinical trials, largely thanks to its extensive healthcare network and premier research institutions. Renowned centers such as UT Southwestern Medical Center, Baylor University Medical Center, and the Texas Health Presbyterian Hospital are at the forefront of clinical research, leading studies across various medical fields.

These institutions are known for their innovative approaches and commitment to advancing medical science, making Dallas, Texas a prominent location for cutting-edge clinical trials and new treatment developments.

Why choose Dallas for clinical trials?

Common conditions studied in Dallas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Dallas